Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about RARE

Recent news which mentions RARE

< Previous 1 2 3 4 Next >
The Latest Analyst Ratings For Ultragenyx Pharmaceutical
Tickers RARE
Tags BZI/AAR Benzinga Market News
From Benzinga
Earnings Scheduled For February 15, 2024
Tickers AEM AGIO AL ALKS
Tags GTX BPMC AGIO
From Benzinga
Preview: Ultragenyx Pharmaceutical's Earnings
Tickers RARE
Tags BZI/EP RARE Market News
From Benzinga
4 Analysts Have This To Say About Ultragenyx Pharmaceutical
Tickers RARE
Tags Market News RARE Analyst Ratings
From Benzinga
Expert Ratings for Ultragenyx Pharmaceutical
Tickers RARE
Tags Market News RARE Analyst Ratings
From Benzinga
Analyst Ratings for Ultragenyx Pharmaceutical
Tickers RARE
Tags Benzinga BZI/AAR Market News
From Benzinga
Earnings Outlook For Ultragenyx Pharmaceutical
Tickers RARE
Tags BZI/EP Earnings Benzinga
From Benzinga
Why Nokia Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Tickers AHG ALPP BCEL BEAM
Tags SMTC UNP HFWA
From Benzinga
AT&T, Union Pacific, Las Vegas Sands And Other Big Stocks Moving Higher On Thursday
Tickers AAL BMI CJET LNN
Tags MTX Penny Stocks big gainers
From Benzinga
Why Nuvve Holding Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Tickers ADD AHG ALB ALBT
Tags IBKR AHG Market News
From Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Tickers ATHX BIO BIOC EIGR
Tags Movers BIOC XGN
From Benzinga
Why Is Mereo BioPharma Stock Trading Higher Today?
Tickers MREO RARE
Tags Market News RARE Benzinga
From Benzinga
The Latest Analyst Ratings for Ultragenyx Pharmaceutical
Tickers RARE
Tags BZI/AAR Benzinga RARE
From Benzinga
Earnings Scheduled For August 3, 2023
Tickers MYGN MYPS NET NGVC
Tags SAND SHAK NNBR
From Benzinga
The Latest Analyst Ratings for Ultragenyx Pharmaceutical
Tickers RARE
Tags Benzinga BZI/AAR Analyst Ratings
From Benzinga
Meta’s stock deemed a high-conviction buy at Citi, as strategy remains ‘underappreciated’
Tickers AIG META RARE TW
Tags TW AIG META
From MarketWatch
The Latest Analyst Ratings for Ultragenyx Pharmaceutical
Tickers RARE
Tags RARE Analyst Ratings Market News
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 6, 2023
Tickers AAPL ABNB AEP AGEN
Tags PEGA LUMN Upgrades
From Benzinga
Apple To Rally Around 17%? Here Are 10 Other Analyst Forecasts For Tuesday
Tickers AAPL ADBE CSTL CXM
Tags CSTL TAP Pre/Market Outlook
From Benzinga
Why Ultragenyx Pharma Stock Is Trading Higher Premarket Today
Tickers MREO RARE
Tags General News Movers
From Benzinga
Ultragenyx Pharmaceutical's Return On Capital Employed Insights
Tickers RARE
Tags RARE Market News Benzinga
From Benzinga
Ultragenyx Pharmaceutical: Q1 Earnings Insights
Tickers RARE
Tags BZI/Recaps Benzinga Earnings
From Benzinga
A Preview Of Ultragenyx Pharmaceutical's Earnings
Tickers RARE
Tags BZI/EP RARE Market News
From Benzinga
Expert Ratings for Ultragenyx Pharmaceutical
Tickers RARE
Tags Benzinga BZI/AAR RARE
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 26, 2023
Tickers ACI BKU BRBR CCEP
Tags BRBR MEC SMG
From Benzinga
7 Biotech Stocks to Buy for Breakthrough Treatments and Cures
Tickers BEAM CRSP EDIT LEGN
Tags LEGN BEAM NASDAQ:LEGN,NASDAQ:CRSP,NASDAQ:ROIV,NASDAQ:EDIT,NASDAQ:BEAM,NASDAQ:RARE,NASDAQ:NTLA
From InvestorPlace
Where Ultragenyx Pharmaceutical Stands With Analysts
Tickers RARE
Tags Market News RARE Analyst Ratings
From Benzinga
Earnings Scheduled For February 16, 2023
Tickers AEL AEM AL ALE
Tags USFD SYNH LTC
From Benzinga
Earnings Preview: Ultragenyx Pharmaceutical
Tickers RARE
Tags Earnings Benzinga Market News
From Benzinga
Analyst Expectations for Ultragenyx Pharmaceutical's Future
Tickers RARE
Tags Market News RARE Analyst Ratings
From Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.